ClinicalTrials.gg
CompletedNCT04392791Updated Sep 29, 2022

Does Balnotherapy Influence the Qualitiy of Life in SLE

An interventional study of balneotherapy in SLE, sponsored by Polyclinic of the Hospitaller Brothers of St. John of God, Budapest. Completed at 1 site in Hungary. Open to participants aged 18 Years to 79 Years. Per ClinicalTrials.gov, last updated 2022-09-29.

Sponsored by Polyclinic of the Hospitaller Brothers of St. John of God, Budapest · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 2 years 5 months after the study started (first participant enrolled Dec 2017, registered May 2020).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 79 Years
Sex
All
01

Study summary

The aim of this study was to investigate the effects of balneotherapy on the quality of life and on work productivity of SLE patients.

Read the detailed description

SLE patients in remission/low disease activity of three immunology centers were included in this randomized, controlled, follow-up study. In addition to the standard of care (SOC) sixteen out of the thirty SLE patients received balneotherapy (15 times, for 30 minutes) and fourteen patients received the SOC only. Prevalidated survey instruments including LupusQol, SF36, and WPAI questionnaires were recorded.

02

Conditions studied

  • SLE
03

In context

Lead sponsor

Polyclinic of the Hospitaller Brothers of St. John of God, Budapest is the lead sponsor of 7 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • diagnosis of SLE according to SLICC/ACR, 2012 criteria;
  • remission or low disease activity, evaluated with SLEDAI-2K

Exclusion criteria

Exclusion Criteria:

  • explorable psychiatric disease
  • general to balneotherapy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Treated group

    The participants received thermal water therapy

    Other: balneotherapy

  • No intervention
    Control group

    The participants haven't received thermal water therapy

Interventions

  • Otherbalneotherapy

    Balneotherapy, a medical remedy, with medically and legally recognized mineral waters for therapeutic and rehabilitation purposes

06

What researchers measure

Primary outcomes

  1. Lupus Quality of Life (LupusQoL)

    Considering the previous4-week period,34 items comprising eight domains, evaluates the physical health, emotional health, body image, pain, planning, fatigue, intimate relationshipsand burden to others. The scoring is made by domains, ranged from 0 (worst) to 100 (best

    Time frame: 10 weeks

  2. WPAI-Lupus is a disease specific questionnaire developed to measure work capacity and daily activity

    Six questions, covering four topics records the prior 7 days impairment: absenteeism, presenteeism, overall work impairment, and activity impairment(Reilly). Evaluation is performed by domain, expressed as a percentage. A higher percentage corresponds to higher impairment, worse productivity.

    Time frame: 10 weeks

  3. The Short Form Health Survey (SF-36)

    Evaluatingthe previous four weeks, it contains a total of 36 questions in 8 categories (physical activity, role limitation due to physical problems, physical pain, general health, vitality, social activity, role limitation due to emotional problems, and general mental health). Responses are rated 0-100 per topic, with 0 being the worst and 100 being the best quality of life

    Time frame: 10 weeks

07

Study locations

1 site
  • Polyclinic of Hospitaller Brothers of St. John of God
    Budapest, 1023, Hungary
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Dec 2017 to primary completion in Jun 2020, 30 months.

How these figures are worked out, and which studies are left out of them.

Registered
May 5, 2020
First posted
May 19, 2020
StartActual
Dec 1, 2017
Primary completionActual
Jun 1, 2020
CompletionActual
Dec 1, 2020
Last update
Sep 29, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 29, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04392791
Lead sponsor
Polyclinic of the Hospitaller Brothers of St. John of God, Budapest
Collaborators
University of Debrecen, Szeged University
Responsible party
Tamás Bender MD, PhD. DSC (MD, PhD. DSC Head of Phisioterapy, Polyclinic of the Hospitaller Brothers of St. John of God, Budapest) — Principal investigator
First posted
May 19, 2020
Start date
Dec 1, 2017
Primary completion
Jun 1, 2020
Completion
Dec 1, 2020
Last update
Sep 29, 2022

Study contacts

Tamás Bender, MD, PhD. DSC
principal investigator

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion